Cryo-Cell International Inc
AMEX:CCEL
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
C
|
Cryo-Cell International Inc
AMEX:CCEL
|
26.9m USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
76.9B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
64.6B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.3B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
24.2B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.2B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
23.1B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.8B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Cryo-Cell International Inc
Glance View
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Cryo-Cell International Inc is 77.1%, which is above its 3-year median of 74%.
Over the last 3 years, Cryo-Cell International Inc’s Gross Margin has increased from 70.1% to 77.1%. During this period, it reached a low of 70.1% on Aug 31, 2022 and a high of 77.1% on Aug 31, 2025.
